SPECT Imaging Scan to Find Source of Epileptic Seizures
By MedImaging International staff writers Posted on 04 Jan 2015 |
Some patients cannot tolerate the side effects of medications that are used to treat epileptic seizures and become candidates for surgery in which the epileptogenic zone in the brain is removed. Surgery is only an option if the affected part of the brain is not responsible for critical functions. Sometimes it is not possible to localize an epileptogenic zone with a Magnetic Resonance Imaging (MRI) scan, or an electroencephalogram.
The Loyola University Health System (Maywood, IL, USA) now performs ictal Single-Photon Emission Computed Tomography (SPECT) scans and uses 3-D modeling software to localize seizures as they occur. The patient is first admitted to the Epilepsy Monitoring Unit where they are continuously monitored for seizures using an Electroencephalography (EEG). When a seizure is detected the patient is injected with a nuclear medicine radiopharmaceutical tracer and undergoes a SPECT scan. The scan, together with the 3-D modeling software, enables the specialists to pinpoint the exact location of the seizure in the brain. This is possible because the radioactive tracer is most prevalent at the epileptogenic zone where blood flow has increase because of the seizure.
According to Bruno Maton, MD, associate professor in the Department of Neurology at Loyola and epilepsy specialist, “SPECT scans require close collaboration between the departments of Radiology and Neurology.”
Related Links:
Loyola University Health System
The Loyola University Health System (Maywood, IL, USA) now performs ictal Single-Photon Emission Computed Tomography (SPECT) scans and uses 3-D modeling software to localize seizures as they occur. The patient is first admitted to the Epilepsy Monitoring Unit where they are continuously monitored for seizures using an Electroencephalography (EEG). When a seizure is detected the patient is injected with a nuclear medicine radiopharmaceutical tracer and undergoes a SPECT scan. The scan, together with the 3-D modeling software, enables the specialists to pinpoint the exact location of the seizure in the brain. This is possible because the radioactive tracer is most prevalent at the epileptogenic zone where blood flow has increase because of the seizure.
According to Bruno Maton, MD, associate professor in the Department of Neurology at Loyola and epilepsy specialist, “SPECT scans require close collaboration between the departments of Radiology and Neurology.”
Related Links:
Loyola University Health System
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment